Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Osteoporotic Fractures prevention & control"" wg kryterium: Temat


Wyświetlanie 1-13 z 13
Tytuł :
Left in limbo – Experiences and needs among postmenopausal women newly diagnosed with osteoporosis without preceding osteoporotic fractures: A qualitative study
Autorzy :
Jakobsen, Pernille Ravn
Hermann, Anne Pernille
Søndergaard, Jens
Wiil, Uffe Kock
Dixon, Ronald F
Clemensen, Jane
Pokaż więcej
Temat :
Obstetrics and Gynaecology
Osteoporosis
medicine.disease
medicine
Qualitative research
Postmenopausal women
Family medicine
medicine.medical_specialty
Health care
business.industry
business
Needs assessment
Patient participation
Disease
Newly diagnosed
Experiences
needs
osteoporosis
postmenopause
qualitative study
Humans
Middle Aged
Patient Participation
Osteoporosis/diagnostic imaging
Absorptiometry, Photon
Osteoporotic Fractures/prevention & control
Healthy Lifestyle
Female
Interviews as Topic
Aged
Qualitative Research
Self Care
Needs Assessment
Patient Education as Topic
Źródło :
Jakobsen, P R, Hermann, A P, Søndergaard, J, Wiil, U K, Dixon, R F & Clemensen, J 2018, ' Left in limbo – Experiences and needs among postmenopausal women newly diagnosed with osteoporosis without preceding osteoporotic fractures : A qualitative study ', Post Reproductive Health, vol. 24, no. 1, pp. 26-33 . https://doi.org/10.1177/2053369118755189
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f424c1a24f0387cca8f15dd949cb0714
Tytuł :
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO
Autorzy :
Diana Frey
Christian Meier
Brigitte Florence Uebelhart
Bérengère Aubry-Rozier
Kurt Lippuner
Olivier Lamy
Heike A. Bischoff-Ferrari
Norbert Suhm
Petra Stute
Serge Ferrari
Martin Birkhäuser
Reto W. Kressig
Pokaż więcej
Temat :
Antibodies, Monoclonal, Humanized/therapeutic use
Bone Density Conservation Agents/therapeutic use
Denosumab/therapeutic use
Diphosphonates/therapeutic use
Evidence-Based Practice
Female
Humans
Osteoporosis/drug therapy
Osteoporotic Fractures/prevention & control
Risk Factors
Time Factors
Rheumatology Clinic and Institute of Physical Medicine
Clinic for Geriatric Medicine
610 Medicine & health
General Medicine
Position statement
Discontinuation
Medicine
business.industry
business
Drug discontinuation
Bisphosphonate
medicine.medical_treatment
Osteoporosis
medicine.disease
Drug treatment
Denosumab
medicine.drug
Intensive care medicine
medicine.medical_specialty
High fracture
ddc:616
Źródło :
Swiss medical weekly, vol. 147, pp. w14484
Meier, Christian; Uebelhart, Brigitte; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike A; Frey, Diana; Kressig, Reto W; Lamy, Olivier; Lippuner, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss Medical Weekly, 147:w14484.
Meier, Christian; Uebelhart, Brigitte; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike A; Frey, Diana; Kressig, Reto W; Lamy, Olivier; Lippuner, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss medical weekly, 147(w14484), w14484. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14484 <http://dx.doi.org/10.4414/smw.2017.14484>
Swiss Medical Weekly, Vol. 147, No w14484 (2017)
Opis pliku :
application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa8193777126a13b4b9c2d0ed00ad0ef
https://serval.unil.ch/notice/serval:BIB_2F7530178F85
Tytuł :
Anti-osteoporotic therapy in Denmark-predictors and demographics of poor refill compliance and poor persistence
Autorzy :
Birthe D. Pedersen
Hanne Konradsen
Carrinna Hansen
Bo Abrahamsen
Pokaż więcej
Temat :
Administration, Oral Adult Aged Aged, 80 and over Bone Density Conservation Agents/administration & dosage/*therapeutic use Cohort Studies Comorbidity Denmark/epidemiology Diphosphonates/administration & dosage/*therapeutic use Female Humans Kaplan-Meier Estimate Male Medication Adherence/*statistics & numerical data Middle Aged Osteoporosis/*drug therapy/epidemiology Osteoporotic Fractures/prevention & control Polypharmacy Risk Factors Socioeconomic Factors
Endocrinology, Diabetes and Metabolism
Osteoporosis
medicine.disease
medicine
Poor compliance
business.industry
business
Oral bisphosphonates
Rheumatology
medicine.medical_specialty
Demographics
Persistence (computer science)
Socioeconomic status
Physical therapy
Internal medicine
Orthopedic surgery
Family medicine
Źródło :
Hansen, C, Pedersen, B D, Konradsen, H & Abrahamsen, B 2013, ' Anti-osteoporotic therapy in Denmark-predictors and demographics of poor refill compliance and poor persistence ', Osteoporosis International, vol. 24, no. 7, pp. 2079-2097 . https://doi.org/10.1007/s00198-012-2221-5
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7042ef40116be9002af6273d6044d735
https://portal.findresearcher.sdu.dk/da/publications/ab681675-e4dd-4827-aa85-bbfab3410382
Tytuł :
Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club
Autorzy :
Yves Boutsen
Pierre Bergmann
Jean-Jacques Body
Steven Boonen
Jean-Pierre Devogelaer
Jean-Marc Kaufman
Stefan Goemaere
Jean-Yves Reginster
Serge Rozenberg
Pokaż więcej
Temat :
Thiophenes
Osteoporotic Fractures
Osteoporosis, Postmenopausal
Organometallic Compounds
Humans
Female
Evidence-Based Medicine
Estrogen Replacement Therapy
Estrogen Receptor Modulators
Diphosphonates
Bone Density Conservation Agents
Aged, 80 and over
Aged
Bisphosphonate
Osteoporosis
Raloxifene
Strontium
Teriparatide
Endocrinology, Diabetes and Metabolism
Evidence-based medicine
Marketing authorization
MEDLINE
Physical therapy
medicine.medical_specialty
medicine
medicine.drug
Public health
Intensive care medicine
Critical appraisal
Evidence-based practice
Health care
business.industry
business
Consensus Statement
Sciences bio-médicales et agricoles
Bone Density Conservation Agents -- therapeutic use
Diphosphonates -- therapeutic use
Estrogen Receptor Modulators -- therapeutic use
Evidence-Based Medicine -- methods
Organometallic Compounds -- therapeutic use
Osteoporosis, Postmenopausal -- drug therapy
Osteoporotic Fractures -- prevention & control
Thiophenes -- therapeutic use
Źródło :
Osteoporosis International : with other metabolic bone diseases, Vol. 21, no. 10, p. 1657-80 (2010)
Osteoporosis International
Osteoporosis international, 21 (10
Opis pliku :
1 full-text file(s): application/pdf
Dostępność :
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cef883227b05edaf52c483cb0ebdaed
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies